Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
40 participants
INTERVENTIONAL
2006-01-31
2009-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study Using Esomeprazole as a Diagnostic Test for GERD in Patients With NCCP
NCT00786695
24 Hour Esophageal and Electrogastrography to Investigate the Mechanism of Reflux Esophagitis
NCT00154570
Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 in Patients With Non-erosive Gastroesophageal Reflux Disease
NCT07160790
Mechanisms Preventing Pharyngeal Reflux
NCT05696184
The Effect of Esomeprazole and Fundoplication on Airways
NCT00994708
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Diagnostic capsule endoscopy
Patient with non-cardiac chest pain will undergo capsule endoscopy
Capsule endoscopy
Patient will undergo a capsule endoscopy for the evaluation of their chest pain.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Capsule endoscopy
Patient will undergo a capsule endoscopy for the evaluation of their chest pain.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* negative cardiac evaluation in the emergency department
* pre-established access to a primary care provider
* ability to give informed consent
Exclusion Criteria
* proton pump inhibitor therapy
* known or suspected obstructions or strictures in the gastrointestinal tract, including a history of Crohn's disease, gastrointestinal surgery other than cholecystectomy or appendectomy.
* permanent pacemakers/defibrillators or other implantable wireless devices
* known pregnancy
* unstable medical conditions
* inability to follow instructions
* active psychiatric conditions that preclude participation in the study
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Brigham and Women's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Brigham and Women's Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Julia J. Liu, MD
Role: PRINCIPAL_INVESTIGATOR
Brigham and Women's Hospital
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2005P001321
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.